×
About 4,735 results

ALLMedicine™ Prostate Biopsy Center

Research & Reviews  1,600 results

Real-world use of MRI for risk stratification prior to prostate biopsy.
https://doi.org/10.1038/s41391-022-00543-4 10.1056/NEJMoa0810696 10.1016/j.eururo.2019.02.009 10.1056/NEJMoa0810084 10.1016/j.juro.2014.10.121 10.1016/S0140-6736(16)32401-1 10.1056/NEJMoa2100852 10.1097/JU.0000000000001406 10.1001/jamaoncol.2018.4160 10.1016/j.urology.2018.04.007 10.2214/AJR.20.23462 10.1111/bju.14151 10.1016/j.juro.2018.01.071 10.1590/S1677-5538.IBJU.2015.0235 10.1001/jamanetworkopen.2021.32388 10.1002/cam4.2149
Prostate Cancer and Prostatic Diseases; Siddiqui MR, Ansbro B et. al.

May 14th, 2022 - The utilization of MRI to risk stratify elevated PSA prior to prostate biopsy has been inconsistently adopted and varies considerably by practice setting. This study aims to evaluate the usage and performance of MRI as an advanced risk stratificat...

Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.
https://clinicaltrials.gov/ct2/show/NCT03228108

May 10th, 2022 - Several classes of antibiotics are proven effective for prophylaxis during transrectal prostate biopsy, reducing infectious complications to less than 1% in case of susceptible rectal flora. Ciprofloxacin has been best studied and is recommended a...

Early Staged Consent Before Prostate Biopsy
https://clinicaltrials.gov/ct2/show/NCT03507725

May 9th, 2022 - This is a study and a novel approach to clinical trials, testing the feasibility and acceptability of two-stage consent in the context of a trial integrated into routine clinical practice. The investigator will use, as a model, a trial of a brief ...

Analysis of the cause of missed diagnosis in mpMRI/TRUS fusion-guided targeted prostate...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074335
BMC Urology; Zhang F, Zhang S et. al.

May 6th, 2022 - To investigate the causes of missed diagnosis in mpMRI/TRUS fusion-guided targeted prostate biopsy. The clinical data of 759 patients who underwent transperineal prostate biopsy from March 2021 to June 2021 at Nanjing DrumTower Hospital were retro...

see more →

Guidelines  3 results

European Association of Urology Position Paper on the Prevention of Infectious Complica...
https://doi.org/10.1016/j.eururo.2020.10.019
European Urology; Pilatz A, Veeratterapillay R et. al.

Nov 12th, 2020 - The transperineal approach is preferred to reduce prostate biopsy (PB)-related infections. Fluoroquinolones are suspended for prophylaxis of PB in the European Union; therefore, alternative antibiotics based on local resistance, or targeted prophy...

Italian Prostate Biopsies Group: 2016 Updated Guidelines Insights.
https://doi.org/10.21873/anticanres.11333
Anticancer Research; Fandella A, Scattoni V et. al.

Feb 10th, 2017 - To present a summary of the updated guidelines of the Italian Prostate Biopsies Group following the best recent evidence of the literature. A systematic review of the new data emerging from 2012-2015 was performed by a panel of 14 selected Italian...

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clini...
https://doi.org/10.1016/j.eururo.2010.10.039
European Urology; Heidenreich A, Bellmunt J et. al.

Nov 9th, 2010 - Our aim was to present a summary of the 2010 version of the European Association of Urology (EAU) guidelines on the screening, diagnosis, and treatment of clinically localised cancer of the prostate (PCa). The working panel performed a literature ...

see more →

Clinicaltrials.gov  100 results

Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.
https://clinicaltrials.gov/ct2/show/NCT03228108

May 10th, 2022 - Several classes of antibiotics are proven effective for prophylaxis during transrectal prostate biopsy, reducing infectious complications to less than 1% in case of susceptible rectal flora. Ciprofloxacin has been best studied and is recommended a...

Early Staged Consent Before Prostate Biopsy
https://clinicaltrials.gov/ct2/show/NCT03507725

May 9th, 2022 - This is a study and a novel approach to clinical trials, testing the feasibility and acceptability of two-stage consent in the context of a trial integrated into routine clinical practice. The investigator will use, as a model, a trial of a brief ...

Decision Impact Trial of the ExoDx Prostate (IntelliScore)
https://clinicaltrials.gov/ct2/show/NCT03235687

May 6th, 2022 - Primary Objective(s) Evaluate performance of the ExoDx Prostate(IntelliScore) (EPI) to reduce the number of initial prostate biopsies by greater than or equal to 15% for men with an elevated Prostate-Specific Antigen 2-10ng/mL presenting for a bio...

Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT03957252

Apr 13th, 2022 - The main objective of this study is to validate ClarityDX Prostate as a reflex test to PSA to refine the prediction of clinically-significant prostate cancer in a prospective cohort of men to be recruited in North America when they are scheduled f...

Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions
https://clinicaltrials.gov/ct2/show/NCT04867603

Apr 11th, 2022 - Individuals with clinical suspicion of prostate cancer and without prior prostate biopsy are offered abbreviated bi-parametric prostate MRI. As Standard of Care (SOC), MRIs will be examined and scored for likelihood for malignancy using the PI-RAD...

see more →

News  181 results

Value of Screening Urinalysis Prior to Office Procedures Questioned
https://www.medscape.com/viewarticle/974014

May 14th, 2022 - Pre-procedure urinalysis can be skipped before certain office-based urology procedures, such as prostate biopsy and cystoscopy, according to the results of a randomized trial. Some centers perform the pre-procedure test to avoid urinary tract infe...

FDA Grants Breakthrough Status to TriNetra-Prostate Blood Test to Detect Early-Stage Prostate Cancer
https://www.onclive.com/view/fda-grants-breakthrough-status-to-trinetra-prostate-blood-test-to-detect-early-stage-prostate-cancer

Feb 15th, 2022 - The FDA has granted a breakthrough device designation to the TriNetra-Prostate blood test for use in the detection of early-stage prostate cancer, according to an announcement from Datar Cancer Genetics, Inc.1 The non-invasive, blood-based liqu...

 NICE Recommends New Diagnostic Devices for Prostate Biopsy
https://www.medscape.com/viewarticle/968489

Feb 15th, 2022 - Transrectal ultrasound guided (TRUS) biopsy has been the gold standard for prostate cancer diagnosis, but carries a significant risk of urinary tract infection, sometimes requiring hospital admission and antibiotics, and potentially leading to sep...

Prostatectomy Without Biopsy Is Feasible, Says German Study
https://www.medscape.com/viewarticle/965729

Dec 29th, 2021 - Radical prostatectomy after confirmation of cancer via two advanced imaging techniques without biopsy is feasible, according to a retrospective study of 25 patients who refused biopsies. "Results of our case series may trigger the discussion about...

FDA Grants 510K Clearance to Exablate System for Prostate Cancer
https://www.onclive.com/view/fda-grants-510k-clearance-to-exablate-system-for-prostate-cancer

Dec 7th, 2021 - The FDA has awarded 510K clearance to the Exablate Prostate system for the treatment of prostate cancer, according to an announcement from the device manufacturer, Insightec.1 Exablate utilizes high intensity focused ultrasound to ablate targeted ...

see more →

Patient Education  10 results see all →